Thync Before You Act – A New Wearable Device Made for 'The Donald'
If you thought people looked foolish wearing Google Glass, wait until you see one of your coworkers sticking a white piece of plastic on her forehead, hooked around her ear. I learned about Thync, a $300 electric gizmo, reading Geoffrey Fowler’s Wall Street Journal column Tuesday.
Fowler tested it, so I don’t have to, but I just know I’ll be seeing this piece of wearable tech around town among the gadgerati I sometimes hang out with. Thync’s unique selling proposition is vibes, uncommonly known as transdermal electrical neuromodulation. Translation—it’s a low-grade form of shock therapy. The company says they’ve tested the device over years of research with their neuroscientists and engineers to give us Calm vibes or Energy vibes.
You’ll have to go to Fowler’s story to view a graphic of how this dildo for the brain actually functions, but Folwer describes the Energy vibe this way: “The sensation is like drinking an espresso, accompanied by a tingle of prickly heat behind the ear.” He compares the hour-long Calm vibe to having a glass of wine.
Like everything else related to wearable tech and the Internet of Things, the company is well funded by Silicon Valley venture capital firms, which are apparently looking for the next Fitbit. And why not? Brain fitness. I know a few people who could benefit from Thync if it works as promised.
Let’s start by getting the company to give one to Donald Trump, set it permanently on the Calm setting, and turn up the juice.
Top Reads from The Fiscal Times:
- Six Amazing Features Hidden in Your Smartphone
- Facebook Must Hand Over NY Users' Info to Prosecutors
- The Incredible Disappearing American-Made Car
Chart of the Day: Boosting Corporate Tax Revenues
The leading candidates for the Democratic presidential nomination have all proposed increasing taxes on corporations, including raising income tax rates to levels ranging from 25% to 35%, up from the current 21% imposed by the Republican tax cuts in 2017. With Bernie Sanders leading the way at $3.9 trillion, here’s how much revenue the higher proposed corporate taxes, along with additional proposed surtaxes and reduced tax breaks, would generate over a decade, according to calculations by the right-leaning Tax Foundation, highlighted Wednesday by Bloomberg News.
Chart of the Day: Discretionary Spending Droops
The federal government’s total non-defense discretionary spending – which covers everything from education and national parks to veterans’ medical care and low-income housing assistance – equals 3.2% of GDP in 2020, near historic lows going back to 1962, according to an analysis this week from the Center on Budget and Policy Priorities.
Chart of the Week: Trump Adds $4.7 Trillion in Debt
The Committee for a Responsible Federal Budget estimated this week that President Trump has now signed legislation that will add a total of $4.7 trillion to the national debt between 2017 and 2029. Tax cuts and spending increases account for similar portions of the projected increase, though if the individual tax cuts in the 2017 Republican overhaul are extended beyond their current expiration date at the end of 2025, they would add another $1 trillion in debt through 2029.
Chart of the Day: The Long Decline in Interest Rates
Are interest rates destined to move higher, increasing the cost of private and public debt? While many experts believe that higher rates are all but inevitable, historian Paul Schmelzing argues that today’s low-interest environment is consistent with a long-term trend stretching back 600 years.
The chart “shows a clear historical downtrend, with rates falling about 1% every 60 years to near zero today,” says Bloomberg’s Aaron Brown. “Rates do tend to revert to a mean, but that mean seems to be declining.”
Chart of the Day: Drug Price Plans Compared
Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.
